Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer
Authors:
Open Access
- 31 January 2012
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 106 (5) , 955-961
Abstract
The incidence of oesophageal adenocarcinoma is increasing worldwide but survival remains poor. Neoadjuvant chemotherapy can improve survival, but prognostic and predictive biomarkers are required. This study built upon preclinical approaches to identify prognostic plasma proteomic markers in oesophageal cancer. Plasma samples collected before and during the treatment of oesophageal cancer and non-cancer controls were analysed by surface-enhanced laser desorption/ionisation time-of-flight (SELDI-TOF) mass spectroscopy (MS). Protein peaks were identified by MS in tryptic digests of purified fractions. Associations between peak intensities obtained in the spectra and clinical endpoints (survival, disease-free survival) were tested by univariate (Fisher's exact test) and multivariate analysis (binary logistic regression). Plasma protein peaks were identified that differed significantly (P<0.05, ANOVA) between the oesophageal cancer and control groups at baseline. Three peaks, confirmed as apolipoprotein A-I, serum amyloid A and transthyretin, in baseline (pre-treatment) samples were associated by univariate and multivariate analysis with disease-free survival and overall survival. Plasma proteins can be detected prior to treatment for oesophageal cancer that are associated with outcome and merit testing as prognostic and predictive markers of response to guide chemotherapy in oesophageal cancer.Keywords
This publication has 35 references indexed in Scilit:
- Glasgow Prognostic Score is a Predictor of Perioperative and Long-term Outcome in Patients with only Surgically Treated Esophageal CancerAnnals of Surgical Oncology, 2010
- Detection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenografts in response to chemotherapyBritish Journal of Cancer, 2010
- Role of Systemic Inflammatory Response in Predicting Survival in Patients with Primary Operable CancerFuture Oncology, 2009
- Inflammation and esophageal carcinogenesisCurrent Opinion in Pharmacology, 2009
- SELDI-TOF MS Whole Serum Proteomic Profiling with IMAC Surface Does Not Reliably Detect Prostate CancerClinical Chemistry, 2008
- Cancer proteomics and its application to discovery of therapy response markers in human cancerCancer, 2006
- The clinical application of proteomicsClinica Chimica Acta, 2005
- Proteomics: The next revolution in laboratory medicine?Clinica Chimica Acta, 2005
- Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?: Table 1Gut, 2005
- Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trialThe Lancet, 2002